TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
AUTOR(ES)
Bradford, P A
RESUMO
TEM-28 (pI 6.1), expressed by an Escherichia coli clinical isolate, is a novel beta-lactamase which hydrolyzed ceftazidime, cefotaxime, and aztreonam with rates of 25, 1.1, and 5.6, respectively, relative to that for benzylpenicillin (100). The nucleotide sequence of blaTEM-28 differed from that of blaTEM-1 by two base changes, resulting in amino acid substitutions of Arg-164 to His and Glu-240 to Lys.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163097Documentos Relacionados
- Extended-spectrum beta-lactamases.
- More extended-spectrum beta-lactamases.
- Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.
- Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
